Phillip Read
Biographic Data
| ID | 5565897 |
|---|---|
| NAME | Phillip Read |
| GIVEN NAMES | Phillip |
| FAMILY NAME | Read |
| SIGNATURE | READ P |
| AFFILIATIONS | UNSW Sydney |
| ORCID | 0000-0001-5422-3777 |
| VERIFIED | Yes |
| TOTAL WORKS | 22 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 22 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2011 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on Opioids
Outreach mpox vaccination at sex-on-premises venues in Sydney
Mpox outreach vaccination done in collaboration between nurses and LGBTQI+ peer-workers at SOPVs proved feasible, acceptable, and beneficial in terms of reaching people who may be out of area and not routinely engaged with sexual health services. Models of care that circumnavigate traditional geographic and local health service barriers should be considered during outbreaks, particularly those that build on established rapport within the communit…
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use
The relatively high incidence of reinfection seen in this study underscores the importance of targeted harm reduction measures and monitoring for HCV reinfections within the first year following successful treatment among people who inject drugs. Additional research into integrated models of care incorporating harm reduction and supporting reducing risk of reinfection and HCV treatment are needed
Needle and syringe sharing among people who have recently injected drugs in Australia
Coverage of cervical cancer prevention interventions among people in Australia who inject drugs
Cervical screening coverage among this sample of people who inject drugs was similar to the Australian population. Health promotion messaging that focuses on the availability of self-sampling and the importance of regular screening may improve coverage among those overdue for screening. HPV vaccination was lower than the general population, warranting targeted efforts to offer the vaccine to eligible people who inject drugs
Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs
Among 2,395 participants enrolled in ETHOS Engage, 66% (n = 1,591) were men, 33% (n = 786) women, and <1% (n = 18) did not identify as a man or woman. HCV testing history and current infection were similar among men and women. Among men or women ever eligible for HCV treatment (ever chronic HCV) (n = 1,242), women were less likely to report a history of HCV treatment compared to men (227/352, 64% vs. 631/890, 71%; p = 0.03). Among women, those ag…
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs
Results highlight important intersections and disparities in stigmatising experiences among people who inject drugs. Considering these intersections can assist health services provide more inclusive care
Critical Success Factors for Intersectoral Collaboration
Introduction: The COVID-19 pandemic disproportionally impacted people experiencing homelessness, including people sleeping rough, people in temporary accommodation and those living in boarding houses. This paper reports on intersectoral responses across six health and social care agencies in Inner Sydney, New South Wales, Australia. Prior to the pandemic the six agencies had established an Intersectoral Homelessness Health Strategy (IHHS), in rec…
Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia
Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program
Point-of-care HCV RNA testing, linkage to nursing, and peer-supported engagement/delivery led to high HCV treatment uptake (majority single-visit) among people with recent injecting drug use attending a peer-led NSP. The lower proportion of people with SVR highlights the need for further interventions to support treatment completion
The Overdose Response with Take Home Naloxone ( ORTHN ) project
The impact of the Covid-19 pandemic on UK medical education. A nationwide student survey
The COVID-19 pandemic had a significant impact on the delivery of medical education across the UK, with the majority of face-to-face teaching cancelled during the first wave, and medical schools consequently making varied adaptations to education delivery. To identify and share effective adaptations, we conducted a cross-sectional, online survey (COVID Med-Ed) between 20th May and 31st August 2020 which divided undergraduate teaching by GMC “Outc…
Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs
Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the Reach-C cohort
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia
Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use
Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting
The acceptability and cost of a home-based chlamydia retesting strategy
The trial was registered with the Australia New Zealand Clinical Trials Registry on September 9, 2011: ACTRN12611000968976
Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting
Goal Attainment Scaling in Early Childhood Intervention
One of the problems about evaluations of outcomes of therapeutic services is the need for quantitative and/or qualitative measurement of attainment of intended goals that is sensitive to small changes over short periods. Goal Attainment Scaling (GAS) was developed by Dr Tom Kiresuk and colleagues (in the United States) in the 1960s to address this issue. While there are many variations and applications of GAS in education and community services, …
No prominent works on this page.
Goal Attainment Scaling in Early Childhood Intervention
One of the problems about evaluations of outcomes of therapeutic services is the need for quantitative and/or qualitative measurement of attainment of intended goals that is sensitive to small changes over short periods. Goal Attainment Scaling (GAS) was developed by Dr Tom Kiresuk and colleagues (in the United States) in the 1960s to address this issue. While there are many variations and applications of GAS in education and community services, …
The acceptability and cost of a home-based chlamydia retesting strategy
The trial was registered with the Australia New Zealand Clinical Trials Registry on September 9, 2011: ACTRN12611000968976
Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting
Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting
Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use
Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the Reach-C cohort
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia
The Overdose Response with Take Home Naloxone ( ORTHN ) project
The impact of the Covid-19 pandemic on UK medical education. A nationwide student survey
The COVID-19 pandemic had a significant impact on the delivery of medical education across the UK, with the majority of face-to-face teaching cancelled during the first wave, and medical schools consequently making varied adaptations to education delivery. To identify and share effective adaptations, we conducted a cross-sectional, online survey (COVID Med-Ed) between 20th May and 31st August 2020 which divided undergraduate teaching by GMC “Outc…
Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs
Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia
Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program
Point-of-care HCV RNA testing, linkage to nursing, and peer-supported engagement/delivery led to high HCV treatment uptake (majority single-visit) among people with recent injecting drug use attending a peer-led NSP. The lower proportion of people with SVR highlights the need for further interventions to support treatment completion
Needle and syringe sharing among people who have recently injected drugs in Australia
Coverage of cervical cancer prevention interventions among people in Australia who inject drugs
Cervical screening coverage among this sample of people who inject drugs was similar to the Australian population. Health promotion messaging that focuses on the availability of self-sampling and the importance of regular screening may improve coverage among those overdue for screening. HPV vaccination was lower than the general population, warranting targeted efforts to offer the vaccine to eligible people who inject drugs
Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs
Among 2,395 participants enrolled in ETHOS Engage, 66% (n = 1,591) were men, 33% (n = 786) women, and <1% (n = 18) did not identify as a man or woman. HCV testing history and current infection were similar among men and women. Among men or women ever eligible for HCV treatment (ever chronic HCV) (n = 1,242), women were less likely to report a history of HCV treatment compared to men (227/352, 64% vs. 631/890, 71%; p = 0.03). Among women, those ag…
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs
Results highlight important intersections and disparities in stigmatising experiences among people who inject drugs. Considering these intersections can assist health services provide more inclusive care
Critical Success Factors for Intersectoral Collaboration
Introduction: The COVID-19 pandemic disproportionally impacted people experiencing homelessness, including people sleeping rough, people in temporary accommodation and those living in boarding houses. This paper reports on intersectoral responses across six health and social care agencies in Inner Sydney, New South Wales, Australia. Prior to the pandemic the six agencies had established an Intersectoral Homelessness Health Strategy (IHHS), in rec…
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use
The relatively high incidence of reinfection seen in this study underscores the importance of targeted harm reduction measures and monitoring for HCV reinfections within the first year following successful treatment among people who inject drugs. Additional research into integrated models of care incorporating harm reduction and supporting reducing risk of reinfection and HCV treatment are needed
Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on Opioids
Outreach mpox vaccination at sex-on-premises venues in Sydney
Mpox outreach vaccination done in collaboration between nurses and LGBTQI+ peer-workers at SOPVs proved feasible, acceptable, and beneficial in terms of reaching people who may be out of area and not routinely engaged with sexual health services. Models of care that circumnavigate traditional geographic and local health service barriers should be considered during outbreaks, particularly those that build on established rapport within the communit…
Medicine (20 works) · Internal Medicine (12 works) · Hepatitis C virus research (11 works) · Family medicine (10 works) · Hepatitis C (8 works) · HIV, Drug Use, Sexual Risk (8 works) · Cohort (6 works) · Hepatitis B Virus Studies (5 works) · Hepatitis C virus (5 works) · Human immunodeficiency virus (HIV (5 works)